Distinctive effects of G-CSF, GM-CSF and TNFα on neutrophil apoptosis in systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 23, Issue 2, 2005, Pages 152-158

  Armstrong, David J ^a,d   Whitehead, Esme M ^a   Crockard, Alistair D ^b   Bell, Aubrey L ^c  

^a NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d MUSGRAVE PARK HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; G CSF; GM CSF; Neutrophils; Rheumatoid arthritis; SLE; TNF

Indexed keywords

AUROTHIOMALATE; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL COUNT; CELLS, CULTURED; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18644375244     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. TAN EM: Anti-nuclear antibodies: diagnostic markers for autoimmume disease and probes for cell biology. Adv Immunol 1989; 44: 93-151.
2. HERMANN M, ZOLLER OM, HAGENHOFFER M, VOLL R, KALDEN JR: What triggers anti-dsDNA antibodies? Mol Biol Rep 1996; 23: 265-7.
3. UMANSKY SR. APOPTOSIS: Molecular and cellular mechanisms (a review). Mol Biol 1996; 30: 285-95.
4. ROSEN A, CASCIOLA-ROSEN L: Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999; 6: 6-12.
5. LEVINE JS, KOH JS: The role of apoptosis in autoimmunity: immunogen, antigen and accelerant. Semin Nephrol 1999; 19: 34-47.
6. NAUTA AJ, DAHA MR, van KOOTEN C, ROOS A: Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol 2003; 24: 148-54.
7. CASCIOLA-ROSEN LA, ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.
8. COURTNEY PA, CROCKARD AD, WILLIAMSON K, IRVINE AE, KENNEDY RJ, BELL AL: Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double-stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58: 309-14.
9. REN Y, TANG J, MOK MY, CHAN AW, LAU CS: Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils. Arthritis Rheum 2003; 48: 2888-97.
10. CAIRNS AP, CROCKARD AD, MCCONNELL JR, COURTNEY PA, BELL AL: Reduced expression of CD44 on monocytes and neutrophils in SLE: relations with apoptotic neutrophils and disease activity. Ann Rheum Dis 2001; 60: 950-5.
11. SAVILL J, DRANSFIELD I, GREGORY C, HASLETT C: A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 965-7.5
12. MCCONNELL JR, CROCKARD, AD, CAIRNS AP, BELL AL: Neutrophils from SLE patients demonstrate increased nuclear DNA damage. Clin Exp Rheumatol 2002; 20: 653-60.
13. AKGUL C, MOULDING DA, EDWARDS SW: Molecular control of neutrophil apoptosis. FEBS Lett 2001; 487: 318-22.
14. STANFORD SJ, PEPPER JR, BURKE-GAFFNEY A, MITCHELL JA: Cytokine-activated human vascular smooth muscle delays apoptosis of neutrophils: relevance of interactions between cyclo-oxygenase-2 and colony stimulating factors. FASEB J 2001; 55: 1813-5.
15. IDRISS HT, NAISMITH JH: TNFα and the TNF receptor superfamily:structure-function relationship. Microsc Res Tech 2000; 50: 184-95.
16. TAKEDA Y, WATANABE H, YONEHARA S, YAMASHITA T, SAITO S, SENDO F: Rapid acceleration of neutrophil apoptosis by TNFα. Int Immun 1993; 5: 691-4.
17. van den BERG JM, WEYER S, WEENING JJ, ROOS D, KUIJPERS TW: Divergent effects of TNFα on apoptosis of human neutrophils. J Leuko Biol 2001; 69: 467-73.
18. MURRAY J, BARBARA JA, DUNKLEY SA, LOPEZ AF, Van OSTADE X: Regulation of neutrophil apoptosis by TNFα: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 1997; 90: 2772-83.
19. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
20. LIANG M, SOCHER SA, LARSEN MG, SCHUR PH: Reliability and validity of six systems for clinical assessment of disease activity in SLE. Arthritis Rheum 1989; 32: 1107-18.
21. van GESTEL AM, HAAGSMA CJ, Van RIEL PL: Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845-50.
22. KOOPMAN G, REUTLINGSBERGER CPM, KUITJEN GAM, KEEHNEN RMJ, PALS ST, van OERS MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-20.
23. ENGELEND M, RAMAEKERS F, SCHUTTE B, REUTLINGSBERGER CPM: A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 1996; 24: 131-9.
24. CAIRNS AP, DUNCAN MK, HINDER AE, TAGGART AJ: New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis. Ann Rheum Dis 2002; 61: 1031-2.
25. EULER HH, HARTEN P, ZEUNER RA, SCHWAB UM: Recombinant human G-CSF in patients with SLE associated neutropenia and refractory infections. J Rheumatol 1997; 24: 2153-7.
26. BENNETT L, PATUCKA AK, ARCE E et al.: Interferon and granulopoiesis signatures in SLE blood. J Exp Med 2003; 197: 681-5.
27. UGUZ A, COSKUN M, YUZBEY S et al.: Apoptosis of cord blood neutrophils and their response to colony-stimulating factors. Am J Perinatol 2002; 19: 427-34.
28. HSIEH S-C, SUN K-H, TSAI C-Y et al.: Monoclonal anti-dsDNA antibody is a leucocyte-binding protein to up-regulate interleukin-8 gene expression and elicit apoptosis of normal human polymorphonuclear neutrophils. Rheumatology 2001; 40: 851-8.
29. HORTNER M, NIELSCH U, MAYR LM et al.: SOCS3 is recruited to the activated G-CSFR and modulates its signal transduction. J Immunol 2002; 169: 1219-27.
30. EDWARDS SW, DEROUET M, HOWSE M, MOOTS RJ: Regulation of neutrophil apoptosis by Mcl-1. Biochem Soc Trans 2004; 32: 489-92.
31. IVANOV VN, BHOUMIK A, RONAI Z: Death receptors and melanoma resistance to apoptosis. Oncogene 2003; 22: 3152-61.
32. MOORE KW, de WAAL MALEFYT R, COFFMAN RL, O'GARRA A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
33. CASSATELLA MA: The neutrophil: one of the cellular targets of interleukin-10. Int J Clin Res 1998; 28: 148-61.
34. LEE A, WHYTE MK, HASLETT C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993; 54: 283-8.